{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T17:20:56Z","timestamp":1768238456498,"version":"3.49.0"},"reference-count":34,"publisher":"Media Sphere Publishing House","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2025,12,30]]},"abstract":"<jats:p>Objective. Study of the efficacy of ampakins (Ampasse) in patients with anxiety and depressive disorders in the early recovery period of ischemic stroke (IS). Material and methods. The study included 203 patients with IS in the early recovery period who underwent rehabilitation measures at the Doctor Clinic medical facility (Tuimazy, Republic of Bashkortostan) in the period from January 2023 to August 2025. The study included patients with a history of IS no later than 3\u20146 months before the start date of the study, with signs of anxiety and depression of varying severity, who scored at least 8 points but no higher than 10 (the level of subclinically expressed symptoms) on the hospital anxiety and depression scale (HADS), as well as those who scored the required number of points on The Montreal Cognitive Function Assessment Scale (MoCA) (at least 10 points). The patients who met the inclusion criteria were randomly assigned to two groups: the experimental group and the control group. In the experimental group, 102 patients received Ampasse therapy in addition to standard therapy. The average age of these patients was 63\u00b18.9 years, 48 of whom were women and 54 were men. In the control group, 101 patients received only basic therapy. The average age of the patients was 66\u00b18.1 years), there were 45 women and 56 men. Throughout the study, the Beck anxiety, Beck depression, HADS, and the Spielberger-Khanin anxiety scales were also used. Results. The dynamics of improvement on all psychometric scales in the experimental group was statistically and clinically more pronounced than in the control group, which received only standard treatment. Conclusion. The results of this study demonstrated the positive effect of Ampasse on reducing the symptoms of anxiety and depression in patients after undergoing AI in the early recovery period.<\/jats:p>","DOI":"10.17116\/jnevro202512512182","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T13:50:31Z","timestamp":1768225831000},"page":"82","source":"Crossref","is-referenced-by-count":0,"title":["Mixed anxiety-depressive disorder in the early period of ischemic stroke and its treatment with ampakines"],"prefix":"10.17116","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-0341","authenticated-orcid":false,"given":"A.L.","family":"Khokhlov","sequence":"first","affiliation":[{"name":"Yaroslavl State Medical University","place":["Yaroslavl, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-8974","authenticated-orcid":false,"given":"E.G.","family":"Lileeva","sequence":"additional","affiliation":[{"name":"Yaroslavl State Medical University","place":["Yaroslavl, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-8770","authenticated-orcid":false,"given":"Yu.V.","family":"Rybachkova","sequence":"additional","affiliation":[{"name":"Yaroslavl State Medical University","place":["Yaroslavl, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4906-5249","authenticated-orcid":false,"given":"Ch.A.","family":"Petrova","sequence":"additional","affiliation":[{"name":"Bashkir State Medical University","place":["Ufa, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3374-7550","authenticated-orcid":false,"given":"E.F.","family":"Oko","sequence":"additional","affiliation":[{"name":"Tuymazy Clinic \u00abDoctor\u00bb","place":["Tuymazy, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1440-524X","authenticated-orcid":false,"given":"O.Yu.","family":"Arseenkova","sequence":"additional","affiliation":[{"name":"N.A. Semashko National Research Institute of Public Health","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8807-405X","authenticated-orcid":false,"given":"A.V.","family":"Kiselev","sequence":"additional","affiliation":[{"name":"Yaroslavl State Medical University","place":["Yaroslavl, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202512512182-1","unstructured":"Arkhincheeva NC, Balkhaev IM, Shadapova AH. Psychoemotional disorders in stroke patients and their modern pharmacotherapy. Bulletin of the Buryat State University. Medicine and Pharmacy. 2024;(1):3-12. (In Russ.)"},{"key":"key-10.17116\/jnevro202512512182-2","doi-asserted-by":"publisher","DOI":"10.31363\/2313-7053-2021-55-2-37-44"},{"key":"key-10.17116\/jnevro202512512182-3","unstructured":"Gusev EI, Gekht AB, Bogolepova AN, et al. Features of depressive syndrome in patients with ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2001;3:28-31. (In Russ.)"},{"key":"key-10.17116\/jnevro202512512182-4","doi-asserted-by":"crossref","unstructured":"Shi Y, Yang D, Zeng Y, et al. Risk factors for post-stroke depression: A Meta-analysis. Front Aging Neurosci. 2017;9:218","DOI":"10.3389\/fnagi.2017.00218"},{"key":"key-10.17116\/jnevro202512512182-5","unstructured":"Mikhailov VA, Druzhinin AK, Shova NI. Affective post-stroke disorders: pathogenesis, diagnosis, treatment. Review of Psychiatry and Medical Psychology named after V.M. Bekhterev. 2018;(1):115-119. (In Russ.)"},{"key":"key-10.17116\/jnevro202512512182-6","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12357"},{"key":"key-10.17116\/jnevro202512512182-7","doi-asserted-by":"crossref","unstructured":"Maksimova MYu, Khokhlova TYu, Suanova ET. Post-stroke depression as a common medical and social problem. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(3):96-103. (In Russ.)","DOI":"10.17116\/jnevro20161163196-103"},{"key":"key-10.17116\/jnevro202512512182-8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1090"},{"key":"key-10.17116\/jnevro202512512182-9","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.8.1506"},{"key":"key-10.17116\/jnevro202512512182-10","unstructured":"Domashenko MA, Maksimova MYu, Orlov SV, et al. Post-stroke depression. Pharmateca. 2011;19:15-19. (In Russ.)"},{"key":"key-10.17116\/jnevro202512512182-11","doi-asserted-by":"crossref","unstructured":"Kasatkina MYu, Zhanin IS, Gulyaeva NV. Biomarkers of stroke and depression: are there specific markers of post-stroke depression? Neurochemistry. 2020;37(4):318-327. (In Russ.)","DOI":"10.1134\/S1819712420040030"},{"key":"key-10.17116\/jnevro202512512182-12","doi-asserted-by":"crossref","unstructured":"Lincoln NB, Brinkmann N, Cunningham S, et al. Anxiety and depression after stroke: A 5 year follow-up. Disabil and Rehab. 2013;35:140-145","DOI":"10.3109\/09638288.2012.691939"},{"key":"key-10.17116\/jnevro202512512182-13","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/258582"},{"key":"key-10.17116\/jnevro202512512182-14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.11.005"},{"key":"key-10.17116\/jnevro202512512182-15","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160044"},{"key":"key-10.17116\/jnevro202512512182-16","unstructured":"Zakharov VV. Glutamatergicheskaya terapiya v vosstanovitel\u2019nom periode posle ishemicheskogo insul\u2019ta. Effektivnaya farmakoterapiya. 2016;42:6-14"},{"key":"key-10.17116\/jnevro202512512182-17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.04.058"},{"key":"key-10.17116\/jnevro202512512182-18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00726.x"},{"key":"key-10.17116\/jnevro202512512182-19","doi-asserted-by":"publisher","DOI":"10.1021\/jm901905j"},{"key":"key-10.17116\/jnevro202512512182-20","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.886918"},{"key":"key-10.17116\/jnevro202512512182-21","unstructured":"Zhang X, Li J, Sha W, et al. Major Depressive Disorder \u2014 Cognitive and Neurobiological Mechanisms. Seoul: InTech; 2015:155"},{"key":"key-10.17116\/jnevro202512512182-22","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-014-0107-0"},{"key":"key-10.17116\/jnevro202512512182-23","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S159855"},{"key":"key-10.17116\/jnevro202512512182-24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2017.01.006"},{"key":"key-10.17116\/jnevro202512512182-25","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.600089"},{"key":"key-10.17116\/jnevro202512512182-26","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-018-4091-0"},{"key":"key-10.17116\/jnevro202512512182-27","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-019-04643-5"},{"key":"key-10.17116\/jnevro202512512182-28","doi-asserted-by":"crossref","unstructured":"Kiselev AV, Vedenkin AS, Stovbun IS. The calcium salt of N-(5-hydroxynicotinoyl)-L-glutamic acid weakens depressive-like behavior and Parkinsonian syndrome in rodents. Bulletin of Experimental Biology and Medicine. 2019;168(7):56-59. (In Russ.)","DOI":"10.1007\/s10517-019-04643-5"},{"key":"key-10.17116\/jnevro202512512182-29","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201911904121"},{"key":"key-10.17116\/jnevro202512512182-30","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202112105126"},{"key":"key-10.17116\/jnevro202512512182-31","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202312310175"},{"key":"key-10.17116\/jnevro202512512182-32","doi-asserted-by":"publisher","DOI":"10.34883\/PI.2024.14.2.046"},{"key":"key-10.17116\/jnevro202512512182-33","unstructured":"Chernykh IV, Shchulkin AV, Mylnikov PYu, et al. The effect of ampakin CX-516 on monoaminergic systems of the brain. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(5):68-74. (In Russ.)"},{"key":"key-10.17116\/jnevro202512512182-34","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202312308277"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T14:02:53Z","timestamp":1768226573000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2025\/12\/1199772982025121082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,30]]}},"alternative-id":["10.17116\/jnevro202512512182"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202512512182","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}